In Vitro Activities of Linezolid against Clinical Isolates of Mycobacterium tuberculosis Complex Isolated in Taiwan over 10 Years
- 1 June 2008
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (6), 2226-2227
- https://doi.org/10.1128/aac.00414-07
Abstract
Significant increases in the MIC 90 s of linezolid in multidrug-resistant Mycobacterium tuberculosis isolates were seen between the baseline period of 2001 to 2003 (0.5 μg/ml) and 2004 (2 μg/ml). The MICs were 4 μg/ml in three strains. Both fluoroquinolones (except levofloxacin) and kanamycin were found to have statistically significant degrees of concordance with linezolid.Keywords
This publication has 8 references indexed in Scilit:
- Importance of the Efflux Pump Systems in the Resistance of Mycobacterium tuberculosis to Fluoroquinolones and LinezolidChemotherapy, 2007
- First Linezolid-Resistant Clinical Isolates of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2007
- In Vitro and In Vivo Activities of Rifampin, Streptomycin, Amikacin, Moxifloxacin, R207910, Linezolid, and PA-824 against Mycobacterium ulceransAntimicrobial Agents and Chemotherapy, 2006
- Mycobacterium tuberculosis in TaiwanJournal of Infection, 2006
- Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995–2003Journal of Antimicrobial Chemotherapy, 2005
- Linezolid: The First Oxazolidinone AntimicrobialAnnals of Internal Medicine, 2003
- In Vitro Activities of Linezolid against Clinical Isolates of Mycobacterium tuberculosis That Are Susceptible or Resistant to First-Line Antituberculous DrugsAntimicrobial Agents and Chemotherapy, 2003
- In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosisInternational Journal of Antimicrobial Agents, 2002